A PVDF receiver for ultrasound monitoring of transcranial focused ultrasound therapy.
Authors: O'Reilly MA, Hynynen K
Focused ultrasound (FUS) shows great promise for use in the area of transcranial therapy. Currently dependent on MRI for monitoring, transcranial FUS would benefit from a real-time technique to monitor acoustic emissions during therapy. A polyvinylidene fluoride receiver with an active area of 17.8 mm (2) and a film thickness of 110 mum was constructed. A compact preamplifier was designed to fit within the receiver to improve the receiver SNR and allow the long transmission line needed to remove the receiver electronics outside of the MRI room. The receiver was compared with a 0.5 mm commercial needle hydrophone and focused and unfocused piezoceramics. The receiver was found to have a higher sensitivity than the needle hydrophone, a more wideband response than the piezoceramic, and sufficient threshold for detection of microbubble emissions. Sonication of microbubbles directly and through a fragment of human skull demonstrated the ability of the receiver to detect harmonic bubble emissions, and showed potential for use in a larger scale array. Monitoring of disruption of the blood-brain barrier in rats showed functionality in vivo and the ability to detect subharmonic, harmonic, and wideband emissions during therapy. The receiver shows potential for monitoring acoustic emissions during treatments and providing additional parameters to assist treatment planning. Future work will focus on developing a multi-element array for transcranial treatment monitoring.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
Develop and evaluate a compact PVDF ultrasound receiver with an integrated preamplifier for real-time monitoring of acoustic (microbubble) emissions during transcranial focused ultrasound therapy.
Animal model / Human subject
Wistar rats
Disease model
healthy
MRI or image guidance method
Custom polyvinylidene fluoride receiver
Targeted brain region(s)
Four Non-Specified Targets
Cargo name and characteristics
Definity contrast agent
Route of administration
intravenous
Outcomes and Safety
Summary of Outcomes
A compact PVDF receiver had higher sensitivity than a 0.5 mm needle hydrophone and a wider bandwidth than piezoceramics, successfully detecting microbubble acoustic emissions through a human skull fragment and in vivo during blood–brain barrier disruption in rats. It reliably detected subharmonic, harmonic and wideband emissions, showing sufficient threshold for microbubble detection and potential for real‑time transcranial monitoring.
Safety-related matter
No adverse effects are reported. The custom receiver enables measuring the interaction between contrast agent microbubbles and the generated sound field during blood-brain barrier opening.
Brain Region
Ultrasound Parameters
Ultrasound instrument
Spherically focused transducer
FUS Frequency
0.558 MHz
FUS Pressure
0.14-0.33
FUS Mode
pulsed
Pulse duration
10 ms
Duration of a single FUS session
2 min
Focal Characteristics
focal length: 78 mm
Treatment frequency
multiple
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search